Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML

Clinical trial NCT03081780 · COMPLETED

Trial details

NCT number

NCT03081780

Sponsor

Masonic Cancer Center, University of Minnesota

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-04-27

Primary completion

2020-08-01

Enrollment

6

View on ClinicalTrials.gov